Meeting to be held in Denver on February 10 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on IMVT: Immunovant Reports Progress Amid Increased R&D Costs Immunovant reports Q3 EPS (76c), consensus (75c) Insider Trading: Immunovant’s (IMVT) Major Investor Boosts Stake by $337M Immunovant price target lowered to $45 from $48 at BofA Immunovant Progresses in Autoimmune Therapy Development Disclaimer & DisclosureReport an Issue